SCHEMBL12415474

SCHEMBL12415474

C=CC1CC(C=C)C(C(=O)OCc2ccccc2)C1C(=O)NCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
FKBP1A P62942 1/20 0.45
FABP7 O15540 1/20 0.43
FABP5 Q01469 1/20 0.43
HPGD P15428 2/20 0.43
USP2 O75604 1/20 0.43
MC4R P32245 1/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HSD17B10 Q99714 1/20 0.40
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
TGM2 P21980 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12415475 0.89 FABP7 (0.42) ALDH1A1TSHRFKBP1AFABP7FABP5
SCHEMBL12415464 0.89 FABP7 (0.52) ALDH1A1TSHRFABP7FABP5CA1
SCHEMBL12415476 0.87 CA1 (0.41) ALDH1A1FKBP1AFABP7FABP5CA1
SCHEMBL12415458 0.79 FABP7 (0.43) ALDH1A1TSHRCYP1A2CYP3A4CYP2C9
SCHEMBL15592928 0.77 CPB1 (0.42) ALDH1A1TSHRCYP1A2CYP3A4CYP2C9
SCHEMBL8694818 0.70 FABP7 (0.50) ALDH1A1FABP7FABP5TGM2POLB
SCHEMBL8694813 0.70 FABP7 (0.50) ALDH1A1FABP7FABP5TGM2POLB
SCHEMBL8694810 0.70 FABP7 (0.50) ALDH1A1FABP7FABP5TGM2POLB
SCHEMBL25836272 0.70 FABP7 (0.52) ALDH1A1FABP7FABP5TGM2KMT2A
SCHEMBL15080525 0.69 FABP7 (0.58) ALDH1A1TSHRCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140080984-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS ZANNA SCITECH CO., LTD. (CN) 2014-03-20 US disclosed
US-20110172381-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS ZANNA SCITECH CO., LTD. (CN) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172381-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS RCSD1, RRP12, TIAM1 ALDH1A1 3240/4885TSHR 3248/4885CYP1A2 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.